achievement of normal fviii activity following gene transfer with valoctocogene roxaparvovec…
Published 4 years ago • 325 plays • Length 17:08Download video MP4
Download video MP3
Similar videos
-
5:08
valoctocogene roxaparvovec gene transfer for severe haemophilia a on health-related quality of life
-
4:39
a post hoc analysis of the gener8 1 phase 3 trial
-
3:54
gener8-1 two-year analysis as presented at eahad
-
6:20
follow-up on gene therapy (flt180a) achieving normal fix activity levels (b-amaze study)
-
0:57
aav gene transfer for hemophilia
-
4:15
spk-8011: stable and durable fviii expression
-
3:00
valoctocogene roxaparvovec aav gene therapy for patients with hemophilia a: new results
-
36:32
gene therapy for fviii
-
5:23
long term expression of aav mediated fviii gene transfer and vector integration events
-
5:50
long-term vector genome outcomes and immunogenicity of aav fviii gene transfer in hemophilia a
-
5:00
valoctocogene roxaparvovec aav gene transfer for severe hemophilia: results from phase 3 trial
-
23:22
role of chromogenic fviii assays in hemophilia a diagnosis
-
1:02:04
multiyear factor viii expression after adeno‐associated virus gene transfer for hemophilia a
-
24:10
how to set up chromogenic fviii and fix assays
-
0:51
empowering patients with hemophilia to make choices about gene therapy
-
2:17
one year follow-up of patients with hemophilia b following spk-9001 gene transfer
-
29:13
chapter 4: genetic assessment
-
1:45:26
one-stage assay of factor viii (fviii) - lab manual video